Catastrophic haemorrhage in a case of paediatric primary antiphospholipid syndrome and factor II deficiency

Lupus

Volumn 6, Issue 1, 1997, Pages 68-71

  Hudson, N ^a,c   Duffy, C M ^b,c   Rauch, J ^a,c   Paquin, J D ^b,c   Esdaile, J M ^a,c  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b MONTREAL CHILDREN S HOSPITAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Antiphospholipid antibodies; Factor II deficiency; Haemorrhage; Primary antiphospholipid syndrome

Indexed keywords

LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; PROTHROMBIN;

ADOLESCENT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLEEDING; CASE REPORT; FEMALE; HUMAN; PRIORITY JOURNAL; PROTHROMBIN DEFICIENCY;

EID: 0031033153     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120339700600110     Document Type: Article

References (20)

1. Asherson RA, Cervera R. Antiphospholipid syndrome. J Invest Dermatol 1993; 100: 21S-27S.
2. Gastineau DA, Kazmier FJ, Nichols WL, Bowie AJW. Lupus anticoagulant: An analysis of the clinical and laboratory features of 219 cases. Am J Haematol 1985; 19: 265-275.
3. Alarcon-Segovia D et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. Medicine (Baltimore) 1989; 68: 353-365.
4. Natleson EA, Cyprus GS, Hettig RA. Absent factor II in SLE. Arthritis Rheum 1976; 19: 79-82.
5. Rauch J, Tannenbaum M, Janoff AS. Distinguishing plasma lupus anticoagulants from anti-factor antibodies using hexagonal (II) phase phospholipids. Thromb Haemost 1989; 62: 892-896.
6. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: An update. Thromb Haemost 1995; 74: 1185- 1190.
7. Tan AM et al. The 1982 revised criteria for the classification of SLE. Arthritis Rheum 1982; 25: 1271-1277.
8. Alarcon-Segovia D, Sanchez-Guerrero J. Primary antiphospholipid syndrome. J Rheumatol 1989; 16: 482-488.
9. Alarcon-Segovia D et al. Preliminary classification criteria for the antiphospholipid syndrome within SLE. Semin Arthritis Rheum 1992; 21: 275-286.
10. Shapiro SS, Thiagarajan P. Lupus anticoagulants. Prog Hemost Thromb 1982; 6:: 263-285.
11. Bajaj SP et al. A mechanism for the hypoprothrombinemia of the acquired hypoprothrombinemia-lupus anticoagulant syndrome. Blood 1983; 61: 684-692.
12. Corrigan JJ, Patterson JH, May NE. Incoagulability of the blood in SLE. A case due to hypoprothrombinemia and a circulating anticoagulant. Am J Dis Child 1970; 119: 365-369.
13. Bernstein ML, Sternbach M, Bellefleur M, Esseltine DW. Thrombotic and haemorrhagic complications in children with the lupus anticoagulant. Am J Dis Child 1984; 138: 1132-1135.
14. Harris EN, Gharavi AE, Hughes GRV. Antiphospholipid antibodies 1985; 11: 591-609.
15. Schwartz S, Esseltine DW. Post extraction haemorrhage in a young male with SLE. Oral Surgery 1984; 57: 254-257.
16. Eberhard A, et al. Hypoprothrombinemia in childhood SLE Semin Arthritis Rheum 1994; 24: 12-18.
17. Bajaj SP, Rapaport SI, Barclay S, Herbst KD. Acquired hypoprothrombinemia due to non-neutralising antibodies to prothrombin: Mechanism and Management. Blood 1985; 65: 1538-1543.
18. Fleck RA, Rapaport SI, Mohan Rao LV. Anti-prothrombin antibodies and the lupus anticoagulant. Blood 1988; 72: 512-519.
19. Bevers EM et al. Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemost 1991; 66: 629-632.
20. 2-glycoprotein 1 in the expression of lupus anticoagulant activity. Blood 1994; 83: 2878-2892.